UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8‑K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):
May 20, 2019

CHEMED CORPORATION
(Exact name of registrant as specified in its charter)

Delaware                         1‑8351                          31‑0791746
(State or other           (Commission File Number)    (I.R.S. Employer
jurisdiction of                                                             Identification
incorporation)                                                                  Number)

2600 First Financial Center, 255 East 5th Street, Cincinnati, OH 45202
(Address of principal executive offices)             (Zip Code)

Registrant's telephone number, including area code:
(513) 762‑6690

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

[_]     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[_]     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)
[_]     Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b))
[_]     Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to 12(b) of the Act:

 
Title of each class
 
Trading symbol
Name of each exchange on which
registered
Capital stock $1 par value
CHE
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.  [_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_]
Page 1 of 3

Item 5.07           Submission of Matters to a Vote of Security Holders

(a)              On May 20, 2019, Chemed Corporation held its annual meeting of stockholders.

(b)      Stockholders voted on the matters set forth below:

Item 1.  Election of Directors.   The following directors, who constitute the entire Board of Directors, were elected at the meeting by the votes indicated:

 
Nominee
 
 
For
 
 
Against
 
 
Abstentions
 
Broker non-
votes
Kevin J. McNamara
 
12,984,787
 
123,443
 
19,461
 
1,123,485
George J. Walsh III
 
10,636,933
 
2,463,422
 
27,336
 
1,123,485
Joel F. Gemunder
 
10,553,403
 
2,545,065
 
29,223
 
1,123,485
Patrick P. Grace
 
10,186,087
 
2,817,212
 
124,392
 
1,123,485
Thomas C. Hutton
 
12,732,063
 
377,111
 
18,517
 
1,123,485
Walter L. Krebs
 
12,442,399
 
660,028
 
25,264
 
1,123,485
Andrea R. Lindell
 
12,959,153
 
143,278
 
25,260
 
1,123,485
Thomas P. Rice
 
13,005,644
 
88,741
 
33,306
 
1,123,485
Donald E. Saunders
 
12,431,985
 
668,004
 
27,702
 
1,123,485
Frank E. Wood
 
12,439,547
 
661,985
 
26,159
 
1,123,485

Item 2.  Ratification of Independent Accountants.   The proposal to ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the company’s independent accountants for the year ending December 31, 2019, was approved with the following votes:

    Voted
 
For
 
13,662,992
   
Against
 
     543,626
   
Abstain
 
       44,558
   

Item 3.  Executive Compensation.   The proposal to approve, on a non-binding basis, the Company’s executive compensation program, was approved with the following votes:

   
Voted

 
For
 
12,528,451
   
Against
 
562,767
   
Abstain
 
36,473
   
Broker non-votes
 
1,123,485
   
Page 2 of 3

Item 4.  Stockholder Proposal.   The stockholder proposal requesting a semi-annual report on (a) the Company’s policies on political spending and (b) political contributions made was disapproved with the following votes

   
Voted

 
For
 
6,025,781
   
Against
 
7,016,935
   
Abstain
 
84,975
   
Broker non-votes
 
1,123,485
   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
 
CHEMED CORPORATION
 
 
 
 
 
 
 
Dated:
May 22, 2019
 
By:
/s/ Michael D. Witzeman
 
 
 
 
 
Michael D. Witzeman
 
 
 
 
 
Vice President and Controller
 


Page 3 of 3
Chemed (NYSE:CHE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Chemed Charts.
Chemed (NYSE:CHE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Chemed Charts.